Why Kenvue Inc. (KVUE) is One of the Best Cheap Stocks to Buy Under $20 [Yahoo! Finance]
Kenvue Inc. (KVUE)
Company Research
Source: Yahoo! Finance
on April 15, maintaining a Neutral rating on the shares and adjusting targets in the beverages, household, and personal care group as part of a fiscal Q1 preview. The firm told investors in a research note that investor focus is likely to be on the sector's margin risk amid higher oil prices and many commodities. Albert Invent Teams Up with Kenvue (KVUE) to Advance Consumer Health Innovation Through AI In another development, Barclays also cut the price target on Kenvue Inc. (NYSE:KVUE) to $18 from $19 on April 14, maintaining an Equal Weight rating on the shares. The rating update came as part of the firm adjusting targets in the consumer staples group in a fiscal Q1 preview, with Barclays telling investors in a research note that it has “growing caution” on the group into the prints because of higher input costs. It also stated that in food, there are now “building concerns” around the sustainability of the dividend for certain companies. Kenvue Inc. (NYSE:KVUE) is a consumer
Show less
Read more
Impact Snapshot
Event Time:
KVUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KVUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KVUE alerts
High impacting Kenvue Inc. news events
Weekly update
A roundup of the hottest topics
KVUE
News
- Kenvue Declares Quarterly Cash DividendBusiness Wire
- Dermal Mycosis Market Research Report 2025-2026 & 2035, Competitive Analysis of Bayer, Kenvue, Karo Healthcare, Novartis, Glenmark Pharmaceuticals, Sun Pharma, Teva, and Sandoz [Yahoo! Finance]Yahoo! Finance
- Kenvue to Announce First Quarter 2026 Results on May 7, 2026Business Wire
- Kenvue (KVUE) had its price target lowered by Citigroup Inc. from $20.00 to $19.00. They now have a "neutral" rating on the stock.MarketBeat
- Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership [TheStreet.com]TheStreet.com
KVUE
Earnings
- 2/17/26 - Beat
KVUE
Sec Filings
- 4/15/26 - Form 8-K
- 4/8/26 - Form ARS
- 4/8/26 - Form DEFA14A
- KVUE's page on the SEC website